ClearPoint Neuro announced the commencement of a proposed underwritten public offering of its shares of common stock. All the shares will be offered by the company. Lake Street Capital Markets is acting as the sole book-running manager for the proposed offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CLPT:
- Is CLPT a Buy, Before Earnings?
- ClearPoint Neuro announces FDA clearance for ClearPoint 2.2 Software
- ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo
- EU MDR certifies ClearPoint Neuro manual SmartTwist Hand Drill and MR Drill Kit
- ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
